Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
Ahmed J Yousuf, Seid Mohammed, Liesl Carr, Mohammadali Yavari Ramsheh, Claudia Micieli, Vijay Mistry, Kairobi Haldar, Adam Wright, Petr Novotny, Sarah Parker, Sarah Glover, Joanne Finch, Niamh Quann, Cassandra L Brookes, Rachel Hobson, Wadah Ibrahim, Richard J Russell, Catherine John, Michele A Grimbaldeston, David F Choy, Dorothy Cheung, Michael Steiner, Neil J Greening, Christopher E Brightling
Topics & Concepts
MedicinePulmonary diseaseInternal medicineClinical trialMEDLINEIntensive care medicinePhase (matter)DiseaseCOPDChronic diseasePhases of clinical researchCardiologyRespiratory diseaseHealth services researchIL-33, ST2, and ILC PathwaysChronic Obstructive Pulmonary Disease (COPD) ResearchInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis